Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Cirrhosis patients with symptomatic portal hypertension might be effectively treated with a transjugular intrahepatic portosystemic shunt stent (TIPS). The intervention, however, carries a risk of debilitating portosystemic hepatic encephalopathy (HE). HE in cirrhosis might be associated with decreased cerebral blood flow (CBF), and CBF might decrease after TIPS.
Original languageEnglish
JournalClinical Gastroenterology and Hepatology
Pages (from-to)1001-3
Number of pages3
Publication statusPublished - 1 Nov 2011

    Research areas

  • Brain, Female, Hepatic Encephalopathy, Humans, Hypertension, Portal, Liver Cirrhosis, Male, Middle Aged, Portasystemic Shunt, Transjugular Intrahepatic, Regional Blood Flow

See relations at Aarhus University Citationformats

ID: 44311759